Alpha Wave Global’s Alto Neuroscience ANRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$97.8M Hold
3,707,757
1.57% 4
2026
Q1
$83.4M Hold
3,707,757
10.54% 2
2025
Q4
$66M Hold
3,707,757
8.09% 2
2025
Q3
$14.9M Hold
3,707,757
1.51% 7
2025
Q2
$8.16M Hold
3,707,757
0.88% 12
2025
Q1
$8.01M Hold
3,707,757
3.57% 5
2024
Q4
$15.7M Hold
3,707,757
7.2% 4
2024
Q3
$42.4M Hold
3,707,757
13.09% 4
2024
Q2
$39.6M Hold
3,707,757
12.98% 4
2024
Q1
$56.9M Buy
+3,707,757
New +$58M 16.93% 2

Other funds holding ANRO

Alpha Wave Global's ANRO Position: Q2 2026 in Review

Alpha Wave Global held its Alto Neuroscience (ANRO) position steady in Q2 2026 at 3,707,757 shares worth $97.8M. The position accounts for 1.57% of the portfolio, ranked #4.

Alpha Wave Global first reported a position in ANRO in Q1 2024 and has held it in 10 quarters since. 114 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • Alpha Wave Global held 3,707,757 shares of Alto Neuroscience worth $97.8M as of Q2 2026.
  • Alpha Wave Global left its Alto Neuroscience share count unchanged in Q2 2026.
  • Alto Neuroscience made up 1.57% of Alpha Wave Global's portfolio in Q2 2026, its #4 holding.
  • Alpha Wave Global first reported a position in Alto Neuroscience in Q1 2024 and has held it in 10 quarters since.
  • 114 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on Alpha Wave Global's 13F filing for Q2 2026, filed 13 Aug 2026.